LENZ Therapeutics Inc (LENZ)
15.70
-0.02
(-0.13%)
USD |
NASDAQ |
May 24, 16:00
15.65
-0.05
(-0.32%)
After-Hours: 20:00
LENZ Therapeutics Cash from Operations (Quarterly): -23.94M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -23.94M |
| September 30, 2023 | -39.41M |
| Date | Value |
|---|---|
| March 31, 2023 | -12.80M |
| September 30, 2022 | 3.372M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-39.41M
Minimum
Sep 2023
3.372M
Maximum
Sep 2022
-18.19M
Average
-18.37M
Median
Cash from Operations (Quarterly) Benchmarks
| TruBridge Inc | -2.034M |
| PetMed Express Inc | -2.593M |
| Streamline Health Solutions Inc | -0.054M |
| R1 RCM Inc | 46.70M |
| MoonLake Immunotherapeutics | -14.95M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 18.00M |
| Cash from Financing (Quarterly) | 171.27M |
| Free Cash Flow | -72.77M |
| Free Cash Flow Per Share (Quarterly) | -5.074 |
| Free Cash Flow Yield | -22.80% |